Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Shares Dive 12 Percent on Widened Loss

NEW YORK, Feb. 2, (GenomeWeb News) - Shares of Luminex were trading down 11.96 percent, or $1.76, at $12.95 in late-afternoon trade on Thursday after the company posted a widened fourth-quarter net loss.


As GenomeWeb News reported this morning, the increased loss came amid higher revenue and a surge in R&D spending.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.